Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Gabapentinoids such as gabapentin and pregabalin quiet nerve pain by binding the alpha-2-delta subunit of voltage-gated calcium channels, reducing the excess neurotransmitter release behind burning, shooting, and tingling sensations. Because the nervous system needs time to adapt, doctors titrate gradually, often beginning with a low bedtime dose and stepping up every few days toward the lowest effective dose with tolerable side effects like drowsiness, dizziness, or swelling. Kidney function, age, body weight, and other sedating medications all change the safe ceiling and the speed of that climb, and meaningful relief may take several weeks rather than days. Stopping suddenly is discouraged, so both increases and tapers are planned deliberately, and there are several important details to consider before judging whether a dose is working, all explained below.
If nerve pain, numbness, or new side effects are making it hard to tell whether your dose needs adjusting or something else is driving your symptoms, a few structured questions can bring clarity fast. Take a free, instant, online symptom check to see which conditions best match what you are feeling and what your most sensible next step should be.
Last reviewed for medical accuracy: 08/18/2026
Neuropathic (nerve) pain can be stubborn and challenging to treat. Two common medications—gabapentin (Neurontin) and pregabalin (Lyrica)—belong to the gabapentinoid class. Doctors tailor (“titrate”) these drugs carefully to balance relief and side effects. Here’s how that process works, why dosing equivalency matters, and what you need to know.
Both drugs:
Titration means starting low and going slow. This approach:
Typical titration phases:
Because gabapentin and pregabalin have different potencies and absorption, direct milligram‐to‐milligram conversion isn’t straightforward. However, rough equivalencies help guide switches:
These equivalencies are approximate and depend on:
Always let your doctor guide any switch or dose adjustment.
Although gabapentinoids are generally well tolerated, they can cause:
Tips for managing side effects:
Your doctor might switch you from gabapentin to pregabalin (or vice versa) if:
A typical switch involves:
For a free, online symptom check, using the doctor approved Ubie Symptom Checker, you can quickly review your nerve pain symptoms and get guidance on whether to discuss changes with your doctor.
Seek medical advice if you experience:
Always speak to a doctor about symptoms that could be life-threatening or serious.
If you have any concerns about your nerve pain, medication schedule, or side effects, speak to a doctor to ensure your treatment plan is right for you.
(References)
* Morris GL. Gabapentin. Epilepsia. 1999;40 Suppl 5:S63-70. doi: 10.1111/j.1528-1157.1999.tb00921.x. PMID: 10530696.
* Davies SJ, Burhan AM, Kim D, Gerretsen P, Graff-Guerrero A, Woo VL, Kumar S, Colman S, Pollock BG, Mulsant BH, Rajji TK. Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia. J Psychopharmacol. 2018 May;32(5):509-523. doi: 10.1177/0269881117744996. Epub 2018 Jan 17. PMID: 29338602; PMCID: PMC5944080.
* Straube A. Pharmacology of vertigo/nystagmus/oscillopsia. Curr Opin Neurol. 2005 Feb;18(1):11-4. doi: 10.1097/00019052-200502000-00004. PMID: 15655396.
* Elger CE, Fernández G. Options after the first antiepileptic drug has failed. Epilepsia. 1999;40 Suppl 6:S9-12; discussion S73-4. doi: 10.1111/j.1528-1157.1999.tb00926.x. PMID: 10530676.
* Robertson K, Marshman LA, Plummer D. Pregabalin and gabapentin for the treatment of sciatica. J Clin Neurosci. 2016 Apr;26:1-7. doi: 10.1016/j.jocn.2015.05.061. Epub 2015 Nov 26. PMID: 26633090.
* Javed S, Alam U, Malik RA. Mirogabalin and emerging therapies for diabetic neuropathy. J Pain Res. 2018;11:1559-1566. doi: 10.2147/JPR.S145999. Epub 2018 Aug 22. PMID: 30174455; PMCID: PMC6110292.
* Ishikawa R, Iseki M. [Pharmacological Treatment of Trigeminal Neuralgia]. No Shinkei Geka. 2024 Jan;52(1):63-69. doi: 10.11477/mf.1436204880. PMID: 38246671.
* Healy P, Verrest L, Felisi M, Ceci A, Della Pasqua O, GAPP Consortium. Dose rationale for gabapentin and tramadol in pediatric patients with chronic pain. Pharmacol Res Perspect. 2023 Oct;11(5):e01138. doi: 10.1002/prp2.1138. PMID: 37803937; PMCID: PMC10558965.
* Naveed S, Faquih AE, Chaudhary AMD. Pregabalin-associated Discontinuation Symptoms: A Case Report. Cureus. 2018 Oct 8;10(10):e3425. doi: 10.7759/cureus.3425. Epub 2018 Oct 8. PMID: 30542635; PMCID: PMC6284877.
* Fleser L, Tibbetts E, Hanson A, Chu EC, Gura K, Tom C, Williams K, Levy P. Evaluating Gabapentin Dosing, Efficacy and Safety in Infants. J Pediatr Pharmacol Ther. 2024 Apr;29(2):159-168. doi: 10.5863/1551-6776-29.2.159. Epub 2024 Apr 8. PMID: 38596422; PMCID: PMC11001217.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.